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ABSTRACT 
An essential element for continuing transmission of Plasmodium falciparum is the 
availability of mature gametocytes in human peripheral circulation for uptake by mosquitoes. 
Natural immune responses to circulating gametocytes may play a role in reducing 
transmission from humans to mosquitoes. Here, antibody recognition of the surface of mature 
intra-erythrocytic gametocytes produced either by a laboratory-adapted parasite, 3D7, or by a 
recent clinical isolate of Kenyan origin (HL1204), was evaluated longitudinally in a cohort of 
Ghanaian school children by flow cytometry. This showed that a proportion of children 
exhibited antibody responses that recognized gametocyte surface antigens on one or both 
parasite lines. A subset of the children maintained detectable anti-gametocyte surface antigen 
(GSA) antibody levels during the 5 week study period. There was indicative evidence that 
children with anti-GSA antibodies present at enrolment were less likely to have patent 
gametocytaemia at subsequent visits (odds ratio = 0.29, 95% CI 0.06 - 1.05; P = 0.034). Our 
data support the existence of antigens on the surface of gametocyte-infected erythrocytes, but 
further are studies are needed to confirm whether antibodies against them reduce gametocyte 
carriage. The identification of GSA would allow their evaluation as potential anti-gametocyte 
vaccines candidates and/or biomarkers for gametocyte carriage.  
 
Key words: Plasmodium falciparum, gametocytes, surface antigens, antibody responses  
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INTRODUCTION 
Malaria is a major global health problem accounting for 198 million cases in 2014, 
and an estimated 584,000 deaths worldwide, 78% of which are thought to occur in African 
children under 5 years 1. Of the six parasite species causing malaria in humans, Plasmodium 
falciparum is the most virulent and the leading cause of morbidity and mortality among 
children under 52. For example in Ghana, malaria accounts for 30% of hospital admissions 
both in pregnant women and children under 5 years, and approximately 8% of these patients 
die every year3. The development of resistance to antimalarials by malaria parasites and to 
insecticides by mosquitoes are increasing challenges4. There is as yet no vaccine for malaria 
control, and targeting of multiple stages of the parasite may be required for any successful 
vaccine-based strategy. As a result there has been renewed interest in the sexual stages of the 
life cycle of malaria parasites, which involves distinctive parasite forms with specific 
morphology, metabolism and biochemical profiles needed to establish infection in the 
mosquito host5 -7. The sexual cycle begins with the development of gametocytes during 
human blood stage infection in all species, but a specific feature of P. falciparum is that only 
mature stage V gametocytes are seen in the peripheral circulation of infected individuals. The 
immature stages I to IV, representing the first 5 to 7 days of development, are instead 
sequestered in internal organs such as bone marrow and spleen8, 9. It had been assumed that 
this is mediated by endothelium receptor-parasite ligand interactions, analogous to those seen 
in cytoadhesion of erythrocytes infected with mature asexual parasites10, 11, but a puzzling 
lack of data to support this paradigm indicated that “...it remains possible that sequestration 
of immature gametocytes in vivo does not require the expression of adhesins on the 
erythrocyte surface”12. Recent studies of changes in deformability of P. falciparum 
gametocyte-infected erythrocytes during their development now show that the physical 
properties of stage I-IV gametocytes, rather than adhesion to endothelium, are more likely the 
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key to their pattern of retention in host tissues, and prevent emergence from sequestered 
niches into the circulation 13, 14. 
Defined immune responses against variant antigens in asexual blood stage parasites 
have been described15, 16. A major target of asexual stage immunity is the variant antigen 
family of PfEMP1, but other known targets include the Rifin17, 18, STEVOR19 and SURFIN 
antigen families20, all of which may contribute to the surface antigen repertoire of asexual 
stage-infected erythrocytes. The var, rif and stevor multi-gene families coding for PfEMP1, 
Rifin and STEVOR proteins, respectively, are also known to be expressed in gametocytes 
and a role in the modification of the gametocyte-infected erythrocyte surface remains a 
possibility13, 21, 22. However, it has not been unequivocally demonstrated that any of these 
variants are surface-exposed on the gametocyte-infected host erythrocyte, or that they have   
a functional role in anti-gametocyte immunity. In fact, there have been few studies on the 
natural immune responses to circulating gametocytes23. In a study of plasma antibodies from 
Gambian children with a known history of gametocyte carriage and mosquito infectivity, we  
found some evidence that surface antigens, identity unknown, on erythrocytes harbouring 
mature gametocytes (GSA) of P. falciparum clone 3D7 were recognised by a subset of 
children24. However, no evidence was found that the targets of these IgG responses were 
adhesins, as reactivity was only found to the most mature stage V gametocytes, which 
circulate in peripheral blood in vivo, and thus are not expected to express adhesins on the 
erythrocyte surface. Gametocyte surface antigens recognised by naturally occurring 
antibodies are potential vaccine candidates, as gametocyte clearance from the circulation 
would result in the interruption of malaria transmission25.  
To better understand antibody responses to P. falciparum GSA, we investigated the 
prevalence and development of such responses in a cohort of school children sampled over a 
5-week period. Antibodies were identified by recognition of  cultured gametocytes from 3D7 
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and from P. falciparum clinical isolates collected in 2012. We addressed the following  
questions: whether natural plasma antibodies recognise GSA on diverse parasite isolates; 
whether GSA antibody levels are maintained longitudinally in individuals; whether carriage 
of GSA antibodies affects concurrent or subsequent gametocytaemia; and whether anti-GSA 
antibodies could be detected in individuals without patent parasitaemia or gametocyte 
carriage.  
  
6 
 
MATERIALS AND METHODS 
Study population and plasma samples  
Plasma samples were obtained from a longitudinal cohort study of asymptomatic 
school children in Pokukrom, in the Ahafo Ano South district of the Ashanti region, Ghana. 
This is an area of high malaria transmission with two seasonal rainfalls. The study 
population, environment, study design and sampling procedures have been described 
previously26. Briefly, asymptomatic school children of Pokukrom Methodist primary between 
the ages of 5 and 12 years were screened for asexual malaria parasites in finger-prick 
peripheral blood. For each sample a rapid immunochromatographic point-of-care test (RDT) 
for antigenaemia was carried out (Malaria Pf rapid test, Shenyang LTH Technology 
Development Company, Beijing, China), blood smears were made for microscopy, and 
approximately 400ul of blood collected into a microtainer for plasma separation. All children 
were clinically examined by a trained nurse to ensure that no child had symptoms suggestive 
of malaria. The medical history and other information of each child were recorded in a case 
report form. The slides were read at Kwame Nakrumah University for Science & Technology 
by experienced microscopists. At the second weekly visit of the study team to the 
participating school, all asymptomatic children with confirmed parasitaemia (sexual or 
asexual or both) at the time of visit 1 were enrolled. Inclusion criteria were: a recorded 
axillary body temperature of less than 37.5 _C, no history of fever in the previous 48 h and 
microscopically confirmed parasitaemia caused by P. falciparum with or without the 
presence of other Plasmodium species. After blood sample collection, all enrollees were 
treated under observation with a standard regimen of dihydroartemisinin-piperaquine, 
comprising 3 daily doses each of 1–3 tablets, depending on the weight and age, of P-
ALAXIN (Bliss GVS Pharma LTD, Mumbai, India), containing 40 mg dihydroartemisinin 
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and 320 mg piperaquine phosphate per tablet.  Enrolled children were followed up for repeat 
finger-prick blood samples weekly for a further 3 weeks.  
Plasma samples were also tested from microscopy-confirmed parasite negative 
individuals and a semi-immune adult individual in convalescence following a successfully-
treated episode of falciparum malaria 3 weeks prior to blood sampling. Negative control 
plasma samples were obtained from malaria-free non-immune European adult donors. The 
study protocols were approved by the Ghana Health Service ethics committee, (reference 
GHS-ERC-08/7/10), and the London School of Hygiene & Tropical Medicine ethics 
committee (reference 5775). In addition, individual and community consent were obtained 
before enrolment into the study. Approval of the study was also required and obtained from 
the Ghana Education Service directorate of the district. 
Parasite prevalence by microscopy 
Asexual parasite and gametocyte carriage were determined by double-read 
microscopy on thick and thin blood smears. Gametocyte density was determined by counting 
gametocytes against 500 leucocytes and asexual parasite densities were estimated from 
counts of asexual parasites against 200 leucocytes as described previously (Fig. 1)27. 
Gametocyte culture and purification 
Gametocytes for antibody-labelling experiments were produced from the 3D7 clone 
of P. falciparum and recent clinical isolates HL1204 and HL120528, according to established 
protocols24, 29 with some modifications as follows. Freshly thawed 3D7 D-sorbitol-
synchronized ring-staged asexual parasites at 4% parasitaemia were used to initiate 
gametocyte production. Asexual blood stage parasites were cultured in human type O 
negative erythrocytes and incomplete RPMI 1640 medium (Sigma, UK) at a haematocrit of 
3% with daily media changes.  Before parasite cultivation, the medium was made complete 
by the addition of 5.96 g l-1 HEPES, 2 gL-1 sodium bicarbonate, 50 mg l-1 hypoxanthine, 3.96 
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g l-1 glucose, 0.003% L-glutamine and 10% pooled blood type AB serum. Cultures were 
incubated at 37°C in a 3% CO2 / 1% O2 / 96% N2 gas phase according to established 
protocols30. Parasite cultures were maintained through an additional asexual cycle, and 
sorbitol  applied when ring-stage trophozoites were abundant in Giemsa-stained films. 
Gametocyte induction was then initiated by first introducing a proportion of spent medium to 
a tightly synchronized fast growing ring stage (day -2) and with a subsequent increase in 
haematocrit from 3% to 5% when early to mid-schizonts were seen (day -1). Another round 
of sorbitol was applied two days later at which point haematocrit was decreased to 3% and 
the culture gave rise to young gametocytes, thus defining day 1 of gametocyte production. N-
acetyl glucosamine (NAG) was applied at a concentration of 55mM throughout gametocyte 
culture to kill any remaining asexual stages29, 31, 32.   
Mature gametocytes (14-15 days old) were harvested and purified for flow cytometry 
experiments with magnet-activated cell sorting (MACS), 18 days after initiating asexual stage 
culture, as described24, 33. Briefly, cultures containing mature stage V gametocytes were 
assessed for ex-flagellation, washed in RPMI and applied to a magnetic cell sorting column 
with 21 G flow resistor at 37°C. Erythrocytes containing paramagnetic mature gametocytes 
were retained in the column while uninfected erythrocytes and debris passed through and 
were discarded. Parasites retained in the column were then released by removal of the 
magnetic field, washed, counted and aliquoted for antibody staining in preparation for flow 
cytometry. These were found overwhelmingly to comprise mature gametocytes within intact 
erythrocyte membranes (Fig. 2), and the majority of these were female. Male gametocytes 
were observed at the expected prevalence of 10 – 20% (Fig. 2B)34.  
For evaluation of antibody recognition of asexual parasite stages, mature schizonts 
and late trophozoites were harvested and purified for flow cytometry experiments by magnet-
activated cell sorting (MACS), as already described. Briefly, parasite cultures were washed in 
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RPMI and applied to a magnetic cell-sorting column with 21G flow resistor at 370C. 
Erythrocytes containing mature parasites, which are paramagnetic, were retained in the 
column while uninfected erythrocytes and debris passed through and were discarded. 
Parasites retained in the column were then released by removal of the magnetic field, washed, 
counted and aliquoted for antibody staining in preparation for flow cytometry. 
Flow cytometry 
Stage V gametocyte-infected erythrocytes enriched by MACS purification were 
incubated with ethidium bromide (EB) at a final concentration of 0.1mg/ml for 1 hour, to 
enable discrimination of nucleic acid-positive infected erythrocytes from uninfected 
anucleate erythrocytes. Aliquots of EB-stained gametocytes (105) were each incubated with 
test plasma samples for 30mins and then with goat anti-human IgG antibody conjugated with 
Alexafluor488 diluted 1:500 for another 30mins. Stained parasites were washed 3 times with 
phosphate buffered saline (PBS) supplemented with 2% foetal calf serum (FCS) 
(PBS/2%FCS) after each antibody staining procedure. The EB- and antibody-labelled 
parasites were then suspended in 300-500µl of PBS/2%FCS and kept at +4°C overnight 
before flow cytometry analysis on the FACSCalibur (Becton Dickinson, UK) 
Antibodies recognizing the surface of gametocyte-infected erythrocytes were detected 
and measured by flow cytometric counting of IgG-labelled, EB-positive mature gametocytes 
according to established protocols for live cells as described24, 35, 36. Before every experiment, 
compensation to exclude spectral overlap was carried out on samples singly-labelled with EB 
or Alexafluor488.  Data acquisition displayed samples in a bivariate plot of side scatter (SSC) 
versus forward scatter (FSC), from which EB versus side scatter plots were derived. A total 
of 10, 000 events were acquired per sample. The EB-positive events were gated against 
uninfected erythrocytes from the same donor source and used to further create bivariate plots 
of side scatter versus Alexafluor488 to assist in exclusion of unstained erythrocytes, dead 
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parasites, debris and non-specific staining (Fig. 3). A singly-stained EB sample which was 
not stained for Alexafluor488 was used to set the Alexafluor488 positive gate position (Fig. 
4) for all samples collected during an experimental session. This fluorescence minus one 
control (FMO) was carried out each time data was acquired on the FACS Calibur. 
For mature gametocytes a total of four experiments were performed using different 
gametocyte preparations of 3D7. The first, 2nd and 3rd experimental sessions comprised 84 
test samples from visit 1, 2 or 5, respectively, plus (as positive controls) 5 Gambian plasma 
samples from treated, symptomatic children who were microscopically-confirmed 
gametocyte carriers, and characterised previously as strong gametocyte-recognisers 24. We 
also included 5 negative controls from European donors who had no known history of 
malaria. Our positive control plasma (known to strongly recognise gametocytes) were also 
tested against the donor erythrocytes used in each experiment, to rule out non-specific 
recognition of the donor cell surface. The order of plasma selection was based on sample 
positions within a series of 96-well plates in which working aliquots were kept. For the first 
84 samples per each visit was any 7 plasma samples per row of 9 samples across 13 rows. A 
fourth experiment included all the remaining test plasma from the three visits (N=29 for each 
of Visit 1, Visit 2 and Visit 5) in one session using a single gametocyte preparation (Table 1). 
Each experiment was performed once. Similar procedures were performed using developing 
and mature gametocytes of HL1204. Twenty-five plasma samples comprising 20 from visit 1 
and 5 from visit 5, characterized in the previous experiments with 3D7, were analysed in the 
HL1204 assay. The basis for selecting these 25 samples was the levels of antibody reactivity 
observed from 3D7 data. The 20 Visit 1 samples represented samples drawn from 5 highly 
reactive, 10 moderately reactive and 5 weakly reactive by our method of analyses. The Visit 
5 samples were from the same individuals as the 5 highly reactive Visit 1 samples. 
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Design of analytical methods and definition of antibody binding 
Flow cytometry data were analysed using flowjo software37. Antibody binding was 
measured first as the percentage of EB-positive cells also labelled by Alexafluor488 (double-
positives: DP). Secondly, geometric mean fluorescence intensity (MFI) of the double-labelled 
cell sub-population was estimated for each sample, at each visit and parasite stage. The %DP 
and MFI estimates for each category were dichotomised using the median as an assumption-
free, transparent cut-off to define strong and weak antibody binding responses. This 
unconventional descriptive approach was deployed to compensate for the absence of 
established cut-offs and gold standard analytical methods. Both parameters were further 
ranked in the order of strong to weak antibody responses.  
Data and statistical analyses 
The proportion of gametocytes labelled by each plasma sample, %DP, was retained as 
a continuous variable, and also transformed into a binary variable using the median value as a 
cut-off. We also analysed %DP using a simple ranking approach. The intensity of gametocyte 
recognition among the double-labelled cells (ie MFI) was analysed similarly, as a continuous 
variable, a binary variable around the median, and by simple ranking. Age in years was 
considered as a continuous variable. Chi-square tests were used to test for statistically 
significant differences between groups in the case of dichotomous variables while Wilcoxon 
rank sum tests were used to test for significant differences between groups in the case of 
continuous variables. Estimation of summary statistics and all tests of associations were 
performed in STATA software (Stata 12.0, Statacorp, Texas, US). Our analyses were based 
on a priori hypothesis-driven questions generated from previous work24. These questions 
were formulated and stated in the study protocol submitted for IRB approval prior to field 
work, and an analysis plan, drawn up before any statistical tests were performed, was 
followed (Dinko B. 2013. PhD Thesis, University of London). For these reasons, we did not 
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apply Bonferroni’s correction to account for random associations due to multiple 
comparisons.   
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RESULTS 
Longitudinal recognition of gametocyte-infected red blood cells of P. falciparum  
We tested immune plasma from 113 asymptomatic Ghanaian school children with 
microscopy-confirmed P. falciparum-infection, representing the “per protocol” cohort from 
our study, having been seen at all five visits by the study team. Antibody recognition of the 
surface of gametocyte-infected erythrocytes was tested by flow cytometry at 3 of the 5 
consecutive weekly timepoints: Visit 1 (day -7; ie day of the first blood film screen to 
identify parasitaemic individuals), Visit 2 (day 0; i.e. when all bloodfilm-positive children 
from Visit 1 received treatment) and Visit 5 (day 21 i.e. four weeks after screening, and three 
weeks after treatment). The microscopic prevalence of asexual and sexual stage P. falciparum 
in these children at each visit is shown in Figure 126. A reduction in asexual parasite 
prevalence between visit 1 and visit 2 could be attributed to immunity but not treatment, as 
the visit 2 sample was taken before drug administration. Children in this cohort harboured 
plasma antibodies which recognized the surface of erythrocytes infected with asexual 
parasites, (Fig. 5; Tables 3 and 4; B. Dinko, PhD Thesis, University of London, 2013) as 
expected24. Children also harboured IgG which recognised erythrocytes infected with mature 
gametocytes, but the level of recognition varied among individuals, and among the three 
timepoints in some individuals (Fig. 4; Tables 3 and 4). Experiments 1, 2 and 3 evaluated 
plasma from timepoints 1, 2 and 5, respectively, for the first 84 participants. Each of the three 
experiments was performed with a different preparation of mature gametocytes. Plasma from 
all three timepoints for the remaining 29 individuals were analysed together in experiment 4, 
utilising a single batch of gametocytes (Table 1). Paired analysis of results compared Visits 2 
(day of treatment) and 5 for both proportion of labelled gametocytes (%DP) and mean 
fluorescent intensity (MFI) for plasma antibody from these 29 individuals. In 23 of these, 
MFI was higher at Visit 2 than at visit 5, indicating a significant reduction in labelling 
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intensity over this 3 week period (P = 0.005; 2-sided sign test). In contrast, only 11 of these 
individuals showed a reduction in %DP estimate at Visit 5 (P = 0.200). Thus a similar 
proportion of gametocytes was labelled by plasma at the two timepoints, but the intensity of 
recognition appeared to have reduced over the 3 week interval between them. In contrast, 62 
of the 84 Visit 5 plasma tested in experiment 3, in which ex-flagellation of gametocytes was 
not seen, identified a lower proportion of labelled gametocytes than had been seen with the 
Visit 2 sample from the same individual in experiment 2, in which ex-flagellation was 
successful (Table 1) (P < 0.0001). One explanation is that the maturity of gametocytes 
differed, and this affected Ab recognition in these two experiments.  
In order to distinguish whether antibody responses to gametocyte-infected 
erythrocytes also recognised asexual stages, we tested for associations between recognition of 
the two parasite stages at each sampling time. There was no association between the 
occurrence of antibody recognising the surface of erythrocytes infected with asexual parasites 
and gametocyte-infected erythrocytes at any time point (Table 2).  Further, there was no 
difference in the likelihood of carrying anti-GSA antibodies between gametocyte-carriers and 
those with only asexual parasites (by microscopy) at Visit 1 (odds ratio (OR) 1.56, 95% CI: 
0.48-5.25; p=0.4).  
Ghanaian plasma antibodies recognize P. falciparum GSA expressed by a Kenyan isolate  
To test directly whether the immune recognition observed in our previous work with 
3D724, a laboratory-adapted parasite line from a Dutch case of airport malaria first described 
in 198128, also occurs with currently circulating African parasites, we further tested plasma 
against mature gametocytes produced from HL1204, a clinical isolate obtained in 2012 from 
a UK falciparum malaria patient who had travelled to Kenya28. Comparable frequency and 
intensity of antibody recognition of the gametocyte surface was observed with HL1204 as 
with the 3D7 clone (Fig. 5). Importantly, these observations showed that gametocytes of East 
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African origin can be recognized by antibodies from West African individuals. Convalescent 
plasma from Ghanaian adult BD, recently treated for clinical malaria caused by P. falciparum 
infection contracted in the study area, also exhibited strong antibody recognition of HL1204 
gametocytes but only weakly recognised asexual parasites (Figure 5). For 14 plasma, we had 
sufficient data to evaluate associations between recognition of 3D7 gametocytes, and those of 
HL1204. Median %DP was significantly higher for the 3D7 gametocytes (43.75%, IQR 19.7 
– 54.9%) than for HL1204 (7.08%, IQR 6.56 – 7.76%), and this difference also held in paired 
analysis for each plasma sample (signrank test P = 0.0010). MFI, in contrast, was greater for 
the HL1204 gametocytes (median 59.7%, IQR 46.1 – 75.7%) than for 3D7 (43.35%, IQR 
37.5 – 47.4%), and this was significant in paired analysis (signrank test P = 0.012). This 
suggests that GSA expression occurred on fewer of our HL1204 gametocytes, despite 
recognition being more intense than on GSA-positive 3D7, consistent with there being 
different proportions of mature, GSA-expressing gametocytes in the two cultured gametocyte 
preparations, but more antibody bound per gametocyte in the HL1204 line. Among the 14 
evaluable plasma samples, neither prevalence nor intensity of recognition of 3D7 
gametocytes by a particular individual at a particular timepoint was associated with higher 
prevalence or intensity, respectively, of recognition of HL1204 gametocytes. Nevertheless, 
when analysed by %DP, 4 of the 14 immune plasma showed stronger recognition of HL1204 
gametocytes compared to 3D7 gametocytes (Fig. 5) and 5 plasma showed stronger responses 
to 3D7 gametocytes compared to HL1204. Five of these plasma samples exhibited strong 
recognition to gametocytes of both parasite lines, by the proportion of gametocyte recognized 
(%DP). Similarly, using the intensity of recognition (MFI), 4 plasma samples showed strong 
antibody binding intensity to gametocytes of both parasite lines and the remaining 10 samples 
recorded intensities that were stronger for gametocytes of HL1204 than 3D7 gametocytes. 
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No detectable antibody binding to the surface of immature gametocytes of a Kenyan isolate 
To test for any immune recognition of the surface of erythrocyte infected with 
immature gametocytes, 25 immune plasma known to recognise GSA were evaluated for 
labelling of erythrocytes infected with developing gametocytes of HL1204. This preparation 
was only partially synchronised, and microscopically determined to comprise 50% Stage IV, 
25% Stage III, and 25% Stage IIa/IIb gametocytes. As previously shown for 3D724, 
detectable levels of antibodies recognizing the surface of erythrocytes infected with immature 
gametocytes of P. falciparum were not observed.  
Plasma antibody responses in parasite negative individuals 
 In order to estimate the prevalence of anti-GSA antibodies in the population as a 
whole, we tested plasma samples from microscopy-confirmed parasite negative children not 
included in the longitudinal study but from the same school cohort. Twenty-four of the 50 
available samples (48%) recognized the surface of gametocyte-infected erythrocytes from 
HL1204 after flow cytometry analysis. 35 individuals also harboured antibodies to the 
surface of asexual parasite-infected erythrocytes. Among the 35 samples showing recognition 
to asexual parasite -infected erythrocytes, 12 had been previously shown to harbour sub-
microscopic parasitaemia by PCR26.  
Anti-GSA antibody recognition and gametocyte carriage 
To determine whether any relationship could be discerned between immune responses 
raised against the surface of gametocyte-infected erythrocytes and continuing carriage of 
gametocytes, we tested for associations between the presence of detectable anti-GSA 
antibodies and carriage of gametocytes over the longitudinal sampling period. No association 
was found between antibody responses to the surface of gametocyte-infected erythrocytes 
and concurrent carriage of gametocytes at any given time point (OR 1.56, 95% CI: 0.48-5.25; 
p=0.4). Gametocytes were detected during follow-up in 16 (17.2%) of the 93 individuals with 
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no detectable gametocytes at visit 1. In 10 of these individuals, this occurred at visit 2, in the 
blood sample taken immediately prior to DP treatment. In one individual this occurred at visit 
4, and in the remaining 5 children gametocytes were microscopically detected for the first 
time at visit 5. There was a weak association between GSA antibody carriage at enrolment 
(%DP > median) and reduced likelihood of the appearance of gametocytes in subsequent 
visits (OR 0.29, 95% CI: 0.06-1.05; p=0.03).  
Prevalence vs Intensity of antibody recognition and relation to age 
The mean fluorescence intensity among double-labelled erythrocytes in our flow 
cytometry plots represents the intensity of antibody binding to the surface of gametocyte-
infected erythrocytes, while %DP denotes the proportion of gametocytes recognized by anti-
GSA antibodies. These are distinct measures, as plasma from some children showed strong 
antibody recognition measured by MFI while only recognising a small percentage of cells, 
and vice versa. These two measures were strongly associated in our dataset at visit 1 (OR 
8.40, 3.35 – 21.4), but not at visit 5 (OR 0.566, 0.251 – 1.27), suggesting fluctuations in the 
quantity and quality of anti-GSA responses in this group of children over time, although 
differences in maturity of gametocyte preparations in the different experiments can only be 
excluded in Expt 4 (Table 1). As immune responses to gametocytes and gametes have been 
shown to be age-dependent38, we investigated the impact of age on GSA antibody prevalence. 
There was weak evidence that children older than the median age of 10 years (range 11 – 17, 
N = 52) were more likely, at visit 1, to already harbour antibodies that recognised the 
gametocyte surface with a high mean fluorescence intensity than were children 10 years or 
younger (range 5 – 10, N = 59; OR 2.15, 95% CI 0.943 – 4.94; P = 0.046). This weak 
relationship was also seen, though non-significant, when %DP was considered (OR 2.08, 
95% CI 0.91 – 4.80; P = 0.058).   
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DISCUSSION 
We have shown that Ghanaian school children with asymptomatic malaria carry 
antibodies that recognize antigens, GSA, on the surface of in vitro-cultured erythrocytes 
infected with P. falciparum gametocytes from two different parasite lines. In contrast, plasma 
antibodies did not recognize immature gametocyte-infected erythrocytes of either the 
laboratory-adapted parasite line 3D7, or from the recent Kenyan isolate HL1204. Anti-GSA 
antibodies were maintained over the study period (5 weeks) in some individuals, and were 
detected among microscopically-confirmed parasite negative children, and in a semi-immune 
adult convalescing from symptomatic malaria. Thus in this high transmission area, 
parasitological status is not a good indicator of likelihood of carriage of antibodies against 
sexual or asexual P. falciparum parasites.  
This study, lasting only a few weeks, does not provide an opportunity to assess 
whether these are long-lived antibody responses, and the relation between human anti-GSA 
antibody responses and recent exposure to gametocytes remains to be fully determined. Also, 
although we found some evidence that carriage of anti-GSA antibodies is associated with 
reduced likelihood of the subsequent appearance of microscopically detectable gametocytes, 
this can only at present be a tentative conclusion subject to many variables.  
Anti-GSA antibodies were detected in microscopically gametocyte-negative 
individuals, but this might be a consequence of sub-microscopic gametocytaemia38. Under 
high transmission, as in our study site, antibodies cannot be matched to any particular episode 
of detectable parasitaemia, as infectious mosquito bites can deliver new parasite inoculations 
regularly. Thus anti-GSA antibody may remain circulating in the (apparent) absence of 
antigens, in contrast with the antibody responses to (non-surface exposed) gamete antigens 
such as Pfs230 and Pfs48/45, which are short-lived and thought to reflect recent exposure to 
gametocytes38-41. Cohort studies of anti-GSA antibody carriage deploying exhaustive RNA-
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based detection of circulating gametocytes, using QT-NASBA or qRT-PCR, are needed to 
fully elucidate this relationship.  
We found strong antibody responses in all three timepoints tested and, in a small 
proportion of children, these were maintained over the study period. In others, fluctuating 
antibody responses were seen, and accurate measurement and comparison of antibody 
responses at single time points can thus be misleading. These findings therefore raise 
questions regarding how to set cut offs for defining antibody responses in a population where 
there is constant exposure to infection. There is also the technical difficulty, when deploying 
large volume, long-term resource-intensive gametocyte cultures, of ensuring the preparations 
are uniform in terms of gametocyte maturity in independent experiments; for example, we 
found some evidence that, when ex-flagellation was not observed (in experiment 3), a lower 
proportion of gametocyte-infected erythrocytes were recognized by IgG, perhaps due to the 
presence of late Stage IV / early Stage V gametocytes not yet presenting the GSA of interest.  
There was unexpected poor antibody recognition at visit 5 which requires further 
investigation to establish whether this was a reproducible change between V2 and V5, or 
attributable to different gametocyte preparations used. Thus, in cultured gametocytes at least, 
the appearance of GSA may be transient and heterogeneous, and hence difficult to capture in 
a synchronous way. Repeat testing of a group of samples across all four experiments would 
have allowed us to address some of these questions. GSA expression patterns might also be 
dimorphic, differing between male and female mature gametocytes. Technical improvements 
in both gametocyte preparation and synchronisation, as well as reliable sex discrimination 
within a more sophisticated multiplex-labelling of parasites for flow cytometry would greatly 
assist in resolving these difficulties. 
The procedure employed sought to prepare very mature gametocytes for the flow 
cytometry experiments, while minimizing the release of female gametes that might be 
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enumerated as positive due to antibody recognition of the gamete surface, rather than that of 
the host erythrocyte. Our experimental design sought to minimise this risk, and checks were 
put in place: gametocytes were handled at 37C, and then immediately chilled on ice prior to 
flow cytometry to minimise ex-flagellation and female gamete emergence, side- and forward-
scatter parameters on the cytometer were set to count only cells with the size and shape of an 
erythrocyte, and Giemsa-stained examination of preparations before (Fig. 2) and after (not 
shown) flow cytometry were examined to verify that erythrocyte membranes are intact. 
While the majority (98%) of labelled cells were apparently intact erythrocytes harbouring 
gametocytes, a few emergent female gametes, known to express antigens recognised by 
naturally-occurring antibody responses 40, 41, may have slipped though the gating strategy and 
contributed to our antibody signal. Future studies could utilise post-flow cytometry 
immunofluorescence staining using gamete markers 21, 42 to determine the number of 
emergent gametes in the gametocyte preparations, or multiplex approaches in which a female 
gamete surface label is included, permitting isolation of these events from the analysis. Male 
gametes will not contribute to this signal as they will not be counted following side- and 
forward-scatter filtering.  
The identity (or identities) of the detected gametocyte surface antigens is not yet 
known. The recognition by Ghanaian plasma antibodies of two different parasite lines 
isolated from different countries and over 30 years apart indicates that GSA, or at least some 
of the component antigens, have a degree of conservation across geographical regions and 
isolates, as has been shown for transmission blocking vaccine candidate Pvs23043. Similar 
findings have been observed in studies of variant surface antigens in asexual parasites where 
plasma antibodies recognized and/or agglutinated parasite isolates regardless of the 
geographical origin of the infected erythrocytes44, 45, showing that components of parasite 
antigens may be conserved across different populations. Our sample size (N=14) in the 
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analysis of cross-reactivity in GSA recognition between the two parasite lines was 
insufficient to adequately explore this question of the level of antigen conservation, and there 
was a lower prevalence of GSA-expressing gametocytes, albeit with high intensity labelling, 
in the HL1204 line. Further work is needed with larger samples, from a wider variety of 
parasite lines. In addition, no association was observed between antibody recognition to 
gametocyte surface by the two parasite lines. This was possibly due to our methodological 
design where 3D7 gametocyte maturation protocols were used for HL1205. In future work, 
specific maturation protocols for HL1204 gametocytes may need to be developed. 
We found no antibody binding to the surface of erythrocytes infected with 
unsynchronised immature gametocytes (stages II, III and IV) from the Kenyan patient isolate. 
This is consistent with an earlier finding24 when testing immature gametocytes from 3D7a, 
and is in line with recent adhesion studies14, 46 which conclude that developing gametocytes 
do not, as previously thought, sequester from the peripheral blood through adhesion to human 
bone marrow derived endothelial surfaces and receptors9, 10, 11. Although we provide no 
evidence that developing gametocytes express surface antigens that may be involved in 
sequestration through parasite ligand – host receptor interactions, we cannot rule this out; 
further studies with tightly synchronised preparations of immature gametocytes are required 
to further explore this question.   
Antibody recognition of the surface of mature gametocyte-infected erythrocytes was 
found to be more common (average prevalence 26% DP) than recognition of asexual 
parasite-infected erythrocytes (average prevalence 6% DP) in plasma taken 3 weeks after 
cure with ACT when tested at the same time by flow cytometry. One possible explanation for 
the low asexual antibody recognition is a rapid decline in antibody titre to the dominant 
variant surface antigens, PfEMP1 25, as seen with anti-merozoite antigens in the absence of 
infection 38, 47, although it may also reflect low surface expression levels of PfEMP1 in our 
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asexual cultures. This decline may also be occurring during asymptomatic carriage in the 
cohort described here. It is known that gametocytes, unlike asexual stages, which are cleared 
by efficacious medication, continue to develop and emerge out of sequestration into 
circulation weeks after malaria treatment 48, 49, and may elicit further immune responses. We 
found no association between presence of GSA antibodies at enrolment and carriage of 
gametocytes at enrolment or during follow-up. However, as mentioned above, we did find a 
weak, but significant reduction in the likelihood of appearance, emergence or development of 
gametocytes later in follow-up among children with anti-GSA antibodies at visit 1. There was 
also a significant association between carriage of GSA antibodies at visit 1 and 2 but not at 
visit 1 and 5, perhaps suggestive of some decay following treatment.   
Our findings support the existence of antigens on the surface of a sub-population of 
mature gametocyte-infected erythrocytes which induce human plasma antibody responses. 
PfEMP1 proteins encoded by the var multi-gene family have been suggested as possible 
GSA10. Transcripts of var genes have been found in late stage gametocytes22 and more 
recently, PfEMP1 have been detected on the surface of early maturing gametocytes but not in 
knobs associated with adhesion as is the case with asexual parasites14. These minimum levels 
of PfEMP1 expression on the surface of immature gametocytes do not support adhesive 
interactions with endothelial receptors and studies of var gene transcription revealed a decline 
in transcript abundance in the later stages of gametocyte development14, 22. The RIFIN and 
STEVOR proteins are also encoded by subtelomeric multigene families, and are expressed in 
later stage gametocytes. Immunofluorescence studies localized these proteins to the plasma 
membrane of gametocyte-infected erythrocytes, but surface exposure has not as yet been 
demonstrated21, 42. Further, the disappearance of STEVOR proteins is correlated with 
deformability of gametocytes as they mature, with less detectable STEVOR proteins in most 
mature deformable stage V gametocytes13. Functional assays are required to test empirically 
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whether STEVOR, Rifins and/or PfEMP1 contribute to the surface of mature gametocyte-
infected erythrocytes, or whether GSA, which our data suggest are heterogeneous molecules 
and only transiently expressed, are encoded by yet unidentified genes. A member of the 
CPW-WPC gene family, previously suggested as a putative GSA12, is now known to be 
expressed in ookinetes50, and thus unlikely to be exposed on the surface of gametocyte-
infected erythrocytes. 
 
CONCLUSIONS 
This study provides the first evidence of P. falciparum gametocyte-specific antibody 
responses in asymptomatic children, and showed that anti-GSA antibodies from Ghanaian 
children were able to recognise GSA of a clinical isolate from Kenya. Anti-GSA antibodies 
were found to be weakly associated with lower risk of gametocyte development 3-4 weeks 
after antibody detection. The identification of the targets of these antibodies is now an 
important goal, which would enable exploration of GSA as candidate transmission- blocking 
vaccine targets, and of anti-GSA IgG as a biomarker of gametocyte carriage.     
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Table 1:  Flow cytometry assays with mature 3D7 gametocytes and relationship to 
sampling visits showing the number and source of samples examined in 
each of the four experiments 
       
  
Ghanaian sampling visits Gambian 
controls 
European 
controls 
Total 
samples 
Experiment *              
Visit1 
 
Visit 2 
 
Visit 5 
     
1 84 0 0 5 5 94 
2 0 84 0 5 5 94 
3 0 0 84 5 5 94 
4 29 29 29 5 5 97 
       *  Each experiment was performed with a different preparation of day 14 mature 
gametocytes of 3D7. Ex-flagellation was observed in the preparations for experiments 1 
and 2, but not for experiments 3 and 4. 
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Table 2: Lack of association between frequency of antibody recognition of the surface 
of erythrocytes infected with 3D7 gametocytes and of erythrocytes infected 
with asexual stages 
Plasma collection 
 timepoint 
Odds 
ratio* 
        95% CI P 
Visit 1 (N= 113) 0.67         0.30 – 1.51 0.29 
Visit 2 (N= 113) 0.60         0.27 – 1.36 0.18 
Visit 5 (N= 113) 1.19         0.48 – 2.93 0.67 
 
*Odds of the proportion of asexual parasites recognised being above the median if the 
proportion of gametocytes recognised is above the median.  
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Table 3:  The proportions of parasites recognized by human IgG (%DP) and the 
intensity of recognition (MFI) of 3D7 gametocytes and asexual stages, 
showing the median and the range for each parasite stage and sample 
collection time point. 
  Gametocytes Asexual stages 
Plasma collection 
time point  
%DP 
Median 
(range) 
MFI     
Median 
(range) 
%DP 
Median 
(range) 
MFI     
Median 
(range) 
Visit 1 (N=113) 
13              
(1-80) 
199          
(52-2493) 
15                
(4-74) 
22               
(18-143) 
Visit 2 (N=113) 
28              
(3-95) 
56               
(40-101) 
7                  
(2-74) 
48           
(38-112) 
Visit 5 (N=113) 
27             
(9-53) 
47            
(38-78) 
9               
(4-47) 
294            
(39-1739) 
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Table 4:  The proportions of parasites recognized by human IgG (%DP) and the 
intensity of recognition (MFI) of HL1204 gametocytes and asexual stages, 
showing the median and the range for each parasite stage and sample 
collection time point. 
  Gametocytes Asexual stages 
Plasma collection 
time point (N) 
%DP 
Median 
(range) 
MFI     
Median 
(range) 
%DP 
Median 
(range) 
MFI     
Median 
(range) 
Visit 1 (N=16) 
18            
(13-36) 
35                          
(23-62) 
26                     
(20-71) 
34              
(20-248) 
Visit 5 (N=4) 
22              
(21-52) 
33           
(25-90) 
18           
(16-20) 
36              
(32-37) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
35 
 
FIGURE LEGENDS 
Figure 1:   Asexual and sexual parasite prevalence in plasma donors for flow 
cytometry experiments.  
The baseline asexual and gametocyte burden of study participants (N = 113) whose plasma 
samples were tested in all flow cytometry experiments. Visit 1 (V1) samples were taken at 
the time of screening to identify parasitaemic children. Visit 2 (V2) samples were collected 
one week later, immediately before drug administration. Visit 5 (V5) samples were taken 3 
weeks after treatment. A small proportion of children still harboured asexual parasitaemia at 
visit 5, three weeks after treatment (26). Error bars: upper 95% CI, estimated from the 
binomial distribution.  
 
Figure 2:  Purification of intact mature gametocytes. 
A. Mature stage V gametocytes under high power oil immersion taken before parasite harvest 
and magnetic purification. The gametocytaemia observed in the sample shown was 16%. 
B. Mature stage V gametocytes under low power objective on a haemocytometer after 
magnetic purification. The gametocytaemia observed is 75%, comprising mostly females. 
Three male gametocytes are indicated.  
 
Figure 3:  Gating strategy for flow cytometric analysis of antibody-labelled 
gametocytes.  
The initial side scatter (SSC) and forward scatter (FSC) plots (left panel) obtained were gated 
out to identify the EB-positive (infected) erythrocyte population (rectangle, middle panel). A 
double-positive population of gametocytes binding to both EB and Alexfluor dyes is then 
derived (in square; right panel), comprising those gametocyte-infected erythrocytes that are 
bound to antibody.  
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Figure 4:  Plasma antibody recognition of mature gametocytes at visits 1, 2 and 5.  
Changes in antibody recognition relative to the first sampling time can be seen. The lower 
antibody levels recorded at visit 5 may be attributable to different gametocyte preparations 
used and not necessarily a reduction in antibody response. 
 
Figure 5:  Comparison of antibody responses to 3D7a and HL1204.  
Antibody reactivity to purified Stage V gametocytes (above) and asexual stages (below) from 
both the 3D7 laboratory clone and the recently-adapted polyclonal clinical isolate HL1204 
(28). Study participant 080 (plasma from Visit 1) strongly recognized both gametocytes and 
asexual parasites from both lines. Convalescent plasma from research team member BD, a 
Ghanaian adult treated for symptomatic malaria at the conclusion of the fieldwork, 
recognized gametocytes of the Kenyan HL1204 parasites more strongly than asexual 
parasites of the same isolate.   
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